Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.84 USD | -4.21% | -1.23% | +35.21% |
Financials (USD)
Sales 2024 * | 304M | Sales 2025 * | 365M | Capitalization | 2.9B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -152M | EV / Sales 2024 * | 9.09 x |
Net cash position 2024 * | 142M | Net cash position 2025 * | 139M | EV / Sales 2025 * | 7.56 x |
P/E ratio 2024 * |
-16.7
x | P/E ratio 2025 * |
-19.7
x | Employees | 919 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.25% |
Latest transcript on Twist Bioscience Corporation
1 day | -4.21% | ||
1 week | -1.23% | ||
Current month | +18.95% | ||
1 month | +3.55% | ||
3 months | +44.21% | ||
6 months | +41.91% | ||
Current year | +35.21% |
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 13-02-03 |
Emily Leproust
CEO | Chief Executive Officer | 51 | 13-03-31 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 16-10-31 |
Jan Johannessen
BRD | Director/Board Member | 67 | 18-09-30 |
Keith Crandell
BRD | Director/Board Member | 63 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 1 M€ | 0.00% | - | |
1.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 49.84 | -4.21% | 968,249 |
24-06-13 | 52.03 | -0.78% | 1,033,699 |
24-06-12 | 52.44 | +1.65% | 1,680,137 |
24-06-11 | 51.59 | +3.16% | 967,025 |
24-06-10 | 50.01 | -0.89% | 969,826 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.21% | 2.9B | |
+0.85% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- TWST Stock